Drug
Vitrase
Vitrase is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
50%
Ph phase_1
2
33%
Ph phase_2
1
17%
Phase Distribution
2
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 33 (50.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
NCT00198458
completedphase_3
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
NCT00198510
completedphase_3
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
NCT00198497
completedphase_2
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
NCT00198471
completedphase_1
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
NCT00198419
Clinical Trials (6)
Showing 6 of 6 trials
NCT00198458Phase 1
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
NCT00198510Phase 3
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
NCT00198497Phase 3
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
NCT00198471Phase 2
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
NCT00198419Phase 1
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
NCT00198484Phase 3
Evaluation of Vitrase as a Spreading Agent
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6